San Diego-primarily based Viking Therapeutics marked itself as a serious competitor during the weight loss drug market place in February right after revealing promising data from a mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in Mar